Quality Management Systems: Class 1 Notes

Course Overview and Logistics

  • Course Title: Quality Management Systems
  • Instructor: Michael Abruto (Mike)
  • Semester: Spring 2026
    • Conducted online due to snowstorm in East Coast.

Class Structure

  • Start Time: 6:00 PM, with a prompt start each week.
  • Duration: Class takes place from 6:00 PM to approximately 9:30 PM. Most classes will finish earlier but some, particularly the favorite lecture on deviation investigations, may extend to 9:30 PM.
  • Breaks: Typically one 15-minute break midway through the class or two short breaks during heavy lecture.

Class Logistics

  • Communication Method: Use Canvas for announcements and class materials.
    • Students are responsible for checking their email addresses provided to the instructor for communication.
  • Syllabus Review: First class included a detailed review of the syllabus and course expectations.
  • Assessments and Deliverables:
    • Midterm Exam on March 2, using Proctorio.
    • Last class on April 6 will aim for final exam to avoid gaps after class.
    • Specific assignments include creating an SOP and a quality plan.

Professor’s Background

  • Experience: 16 years as a professor; 28 years in the industry.
    • Background includes bench chemist, quality control, production, to quality assurance.
    • Current role as Vice President of Gemma Biotherapeutics, with prior roles at GSK and University of Pennsylvania.
  • Educational Development: Course developed based on experience needs in GMP-focused quality management systems, including ICH guidelines.

Course Content and Structure

Key Focus Areas

  • Regulatory Frameworks:
    • ICH Q8 (Pharmaceutical Development)
    • ICH Q9 (Quality Risk Management)
    • ICH Q10 (Pharmaceutical Quality Systems)
  • Topics Covered:
    • Development and maintenance of SOPs,
    • Nonconformance systems,
    • Corrective/Preventive Actions (CAPA),
    • Supplier and change management,
    • Validation, and process controls through KPIs.
    • Will include lab quality systems discussing training, deviations, and quality control-related principles.

Course Objectives

  • Understand pharmaceutical quality system requirements.
  • Identify critical areas for inspection readiness.
  • Develop SOPs and quality plans, enhancing understanding through practical exercises.
  • Understand process monitoring and establish effective KPIs.

Syllabus Details

  • Class Schedule:
    • Class 1: January 26
    • Class 2: February 2 (recording available)
    • Class 3: February 9
    • Class 4: February 16 (recording available)
    • Class 5: February 23 (SOP topic due, quiz)
    • Class 6: March 2 (Midterm exam)
    • No class on March 16.
    • Last class on April 6, potential final exam.
  • External Resources: Suggested text not mandatory but valuable for supplemental understanding in quality systems.

Key Regulation and Definitions

  • GMP Regulations: Governed by Part 210 and 211, important for maintaining quality in pharmaceutical products.
  • Regulatory Bodies: Includes FDA, ICH, and Health Canada among others. Each brings differing requirements but focuses on ensuring patient safety and product efficacy.

Student Participation and Communication

  • Interactions: Engaged learning encouraged—students are invited to share relevant experiences during discussions.
  • Attendance Policy: Importance of attending sessions highlighted, with the expectation of keeping cameras on during discussions to promote active engagement.
  • Grading Criteria: Participation (5%), Midterm (25%), Quiz (10%), SOP Assignment (15%), Quality Plan (15%), Final Exam (30%).
  • Emergency Procedures: Potential for class cancellations discussed, although online formats reduce this risk.

Quality Management Systems Fundamentals

QA and QC

  • Quality Assurance (QA): The process ensuring that quality is built into the product—emphasizing that it involves everyone, not just the QA department.
  • Quality Control (QC): Focused on assessing product quality through testing—relatively narrow scope compared to QA.

Quality Culture'

  • Company-wide Quality Responsibility: Quality should not be the sole responsibility of QA; involvement from all sectors of the organization is essential for a quality culture.
  • Quality Systems Aim: To foster a continuous improvement methodology through effective preventive and corrective measures bolstered by risk management principles.

Continuous Improvement and Innovation

  • Emphasizes the need for a proactive stance in quality management, adopting practices such as Lean and Six Sigma methodologies to enhance efficiency and effectiveness in quality assurance processes.
  • Development of Quality Management Systems not only addresses current needs but prepares for future challenges by embedding a culture of quality improvement.

Regulatory Interactions

  • Highlights importance of compliance with regulations and frameworks to avoid potential observations and maintain a positive standing with regulatory bodies.
    • FDA 483 Observations: The most common observations from inspections involve failure to follow documented procedures or insufficient investigations into quality failures.

Inspection Readiness

  • Emphasized as critical for all students and professionals in the pharmaceutical industry. Key to ensuring robustness in product quality and compliance with regulatory standards.

Conclusion of Class Structure

  • The class will follow a structured pathway, moving through quality management systems topics and continuously looking to build on feedback for understanding.
  • Emphasis on blending theory with practical experiences will be maintained throughout the semester.
  • Encouragement of an interactive format to optimize learning and engagement among students throughout the course.